| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |